Dihydromyricetin (DHM, vine tea extract)
Dihydromyricetin (DHM / Ampelopsin) · also known as Dihydromyricetin, Vine tea flavonoid, Ampelopsin, DHM
Dihydromyricetin is a flavonol found in vine tea and other plants. Animal studies show it can alter the expression of alcohol-metabolizing enzymes, but there is no reliable evidence that it speeds acetaldehyde clearance or relieves intoxication or hangovers in humans.
Clinical uses and human evidence
Blood sugar and insulin resistance
High LDL cholesterol
Fatty liver and liver enzymes
Studies (2)
- Chen 2015 · Pharmacol Res · RCT · n=60 — Dihydromyricetin improves glucose and lipid metabolism and exerts anti-inflammatory effects in nonalcoholic fatty liver disease: A randomized controlled trial
- Michailidou 2026 · Ann Gastroenterol · RCT · n=55 — Dietary supplement based on dihydromyricetin in metabolic dysfunction-associated steatotic liver disease: a double-blind, placebo-controlled, randomized clinical trial
Mechanisms of action
Aldehyde dehydrogenase (ALDH2) activation and clearance of ethanol’s mitochondrial toxicity
Animal experiments suggest dihydromyricetin can alter hepatic ADH1 and ALDH2 expression and affect blood ethanol and acetaldehyde levels after alcohol exposure. There is no reliable human evidence that it allosterically activates ALDH2 or lowers peak acetaldehyde, and tissue exposure after oral dosing is also limited.
GABA and glutamate balance (inhibitory and excitatory tone)
Rat and isolated-receptor experiments show that dihydromyricetin can reduce some ethanol effects linked to GABA-A receptors. Most of these studies gave it by injection, so they do not show that usual oral doses reach effective concentrations in the human brain.
AMPK sensing of cellular energy deficit and metabolic reprogramming
In mice, hepatic AMPK phosphorylation increased and related mitochondrial markers also changed. There is no evidence of an AMPK response in human tissue at usual oral doses, and its effect on fatty liver in humans has not been verified.